elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26823757-40655650-4691-41EF-B2F3-7B53EF763FE8
Q26823757-40655650-4691-41EF-B2F3-7B53EF763FE8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26823757-40655650-4691-41EF-B2F3-7B53EF763FE8
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)
P407
Q26823757-40655650-4691-41EF-B2F3-7B53EF763FE8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26823757-40655650-4691-41EF-B2F3-7B53EF763FE8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0f777b69d8d3a65ccde0a935ad2e100b32e54ef9
P407
English